Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive miRNA-188 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, 13/October/2014, 21.49

Chemopreventive therapy against Human Cancer: Natural product Cucurbitacin I inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 13/October/2014, 18.59
October 13, 2014
Lifespan extention therapy: Tanshinone IIA, a well known Chinese medicine, increases life expectancy via down regulation of its target gene, 14/October/2014, 6.27 am
October 14, 2014
Show all

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical SchoolBoston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression.”

This study was published in the June 26, 2014 Nature [I.F >42] by Prof. Puigserver and others from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMDreports here that: Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive MicroRNA-188 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1.  This study may suggest that miRNA-188, by down regulating its target gene, it may promote  gluconeogenesis and hyperglycemia. Together, this study suggests that pharmacological formulations encompassing “anti-miRNA-188 or small molecule inhibitors of miRNA-188″  can be used in the treatment of NIDDM.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive miRNA-188 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, 13/October/2014, 21.49, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.